NYSE:SYK - Stryker Stock Price, Price Target & More

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Stryker declared a quarterly dividend on Wednesday, February 7th. Shareholders of record on Thursday, March 29th will be paid a dividend of $0.47 per share on Monday, April 30th. This represents a $1.88 annualized dividend and a yield of 1.15%. The ex-dividend date is Wednesday, March 28th. View Stryker's Dividend History.

Stryker Co. (NYSE:SYK) released its quarterly earnings data on Tuesday, January, 30th. The medical technology company reported $1.96 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.95 by $0.01. The medical technology company earned $3.47 billion during the quarter, compared to analyst estimates of $3.42 billion. Stryker had a return on equity of 24.56% and a net margin of 8.20%. Stryker's revenue for the quarter was up 9.9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.78 EPS. View Stryker's Earnings History.

Stryker is scheduled to release their next quarterly earnings announcement on Thursday, April, 26th 2018. View Earnings Estimates for Stryker.

Stryker issued an update on its FY18 earnings guidance on Tuesday, January, 30th. The company provided earnings per share (EPS) guidance of $7.07-7.17 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.13. Stryker also updated its Q1 guidance to $1.57-1.62 EPS.

24 Wall Street analysts have issued 12-month price objectives for Stryker's shares. Their predictions range from $129.00 to $186.00. On average, they expect Stryker's share price to reach $164.7143 in the next twelve months. View Analyst Ratings for Stryker.

Stryker saw a drop in short interest in the month of March. As of March 29th, there was short interest totalling 5,374,898 shares, a drop of 36.3% from the March 15th total of 8,444,053 shares. Based on an average daily volume of 1,188,121 shares, the short-interest ratio is presently 4.5 days. Currently, 1.5% of the company's stock are short sold.

Some companies that are related to Stryker include 3M (MMM), Becton Dickinson (BDX), Fresenius (FSNUY), Boston Scientific (BSX), Baxter International (BAX), ResMed (RMD), Abiomed (ABMD), Teleflex (TFX), Dexcom (DXCM), Hill-Rom (HRC), ICU Medical (ICUI), Insulet (PODD), Globus Medical (GMED), Cantel Medical (CMD) and Penumbra (PEN).

Press coverage about SYK stock has trended somewhat positive this week, according to Accern Sentiment. Accern rates the sentiment of media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Stryker earned a media sentiment score of 0.03 on Accern's scale. They also gave media stories about the medical technology company an impact score of 46.08 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of SYK stock can currently be purchased for approximately $164.10.

Stryker has a market capitalization of $61.53 billion and generates $12.44 billion in revenue each year. The medical technology company earns $1.02 billion in net income (profit) each year or $6.49 on an earnings per share basis. Stryker employs 33,000 workers across the globe.

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]